Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients.

Polycystic ovary syndrome (PCOS) represents the most common cause of anovulatory infertility and affects 5-10% of women of reproductive age. The etiology of PCOS is still unknown. The current study is the first to describe consistent differences in gene expression profiles in human ovaries comparing PCOS patients vs. healthy normoovulatory individuals. The microarray analysis of PCOS vs. normal ovaries identifies dysregulated expression of genes encoding components of several biological pathways or systems such as Wnt signaling, extracellular matrix components, and immunological factors. Resulting data may provide novel clues for ovarian dysfunction in PCOS. Intriguingly, the gene expression profiles of ovaries from (long-term) androgen-treated female-to-male transsexuals (TSX) show considerable overlap with PCOS. This observation provides supportive evidence that androgens play a key role in the pathogenesis of PCOS. Presented data may contribute to a better understanding of dysregulated pathways in PCOS, which might ultimately reveal novel leads for therapeutic intervention.

[1]  Hughes Pe.  Morphology and Morphogenesis of the Stein-Leventhal Ovary and of So-called “Hyperthecosis” , 1982 .

[2]  H. S. Jacobs,et al.  MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE , 1985, The Lancet.

[3]  T. Mori,et al.  EDITORIAL: Immuno‐Endocrinology of Cyclic Ovarian Function , 1990, American journal of reproductive immunology.

[4]  A. Lanzavecchia,et al.  Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. , 1990, Annual review of immunology.

[5]  L. Gooren,et al.  Ovarian morphology in long‐term androgen‐treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? , 1991, Histopathology.

[6]  W. Hop,et al.  17β‐Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals * , 1992, Clinical endocrinology.

[7]  H. Inoko,et al.  Human leukocyte antigen-DR is a differentiation antigen for human granulosa cells. , 1993, Biology of reproduction.

[8]  P. J. Rowe,et al.  WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple , 1993 .

[9]  Shulin Li,et al.  The Pem Homeobox Gene , 1996, The Journal of Biological Chemistry.

[10]  L. Tessarollo,et al.  An essential role for C/EBPbeta in female reproduction. , 1997, Genes & development.

[11]  A. Dunaif,et al.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.

[12]  W. Hop,et al.  Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. , 1997, Fertility and sterility.

[13]  M. McCarthy,et al.  Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome , 1997, The Lancet.

[14]  H. Sasano,et al.  Leukocytes in Normal-cycling Human Ovaries: Immunohistochemical Distribution and Characterization , 2022 .

[15]  T. Key,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study* , 2022 .

[16]  M. Urbanek,et al.  Phenotype and genotype in polycystic ovary syndrome. , 1998, Recent progress in hormone research.

[17]  R. Legro,et al.  Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. , 1999, Molecular endocrinology.

[18]  Peter Scheurich,et al.  Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF‐R1 activation by endogenous membrane‐anchored TNF , 1999, The EMBO journal.

[19]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[20]  G. Firestone,et al.  Functional and subcellular changes in the A-kinase-signaling pathway: relation to aromatase and Sgk expression during the transition of granulosa cells to luteal cells. , 1999, Molecular endocrinology.

[21]  C. Solomon,et al.  The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. , 1999, Endocrinology and metabolism clinics of North America.

[22]  M. Urbanek,et al.  Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Bowtell,et al.  Options available — from start to finish — for obtaining expression data by microarray , 1999, Nature Genetics.

[24]  H Nau,et al.  New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta). , 1999, Toxicology and applied pharmacology.

[25]  M. Urbanek,et al.  Searching for the polycystic ovary syndrome genes. , 2000, Journal of pediatric endocrinology & metabolism : JPEM.

[26]  A. Arıcı,et al.  Leukocytes in ovarian function. , 2000, Human reproduction update.

[27]  L. Hartmann,et al.  Prophylactic surgery for women at high risk for breast cancer. , 2000, Clinical breast cancer.

[28]  P. G. Quinn,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Differential Activity of the Cytochrome P450 17�- Hydroxylase and Steroidogenic Acute Regulatory Protein Gene Promoters in Normal and Polycystic , 2022 .

[29]  Ping Zhu,et al.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.

[30]  T. Sasaki,et al.  Recombinant domains of mouse nidogen-1 and their binding to basement membrane proteins and monoclonal antibodies. , 2001, European journal of biochemistry.

[31]  S. Weitsman,et al.  Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. , 2001, The Journal of clinical endocrinology and metabolism.

[32]  M. Eijkemans,et al.  Absent biologically relevant associations between serum inhibin B concentrations and characteristics of polycystic ovary syndrome in normogonadotrophic anovulatory infertility. , 2001, Human reproduction.

[33]  P. Crosignani,et al.  Polycystic ovarian disease: heritability and heterogeneity. , 2001, Human reproduction update.

[34]  A. Zorn,et al.  Wnt signalling: Antagonistic Dickkopfs , 2001, Current Biology.

[35]  M. Knip,et al.  Altered ovarian function and cardiovascular risk factors in valproate-treated women. , 2001, The American journal of medicine.

[36]  C. Geserick,et al.  OTEX, an androgen-regulated human member of the paired-like class of homeobox genes. , 2002, The Biochemical journal.

[37]  E. Adashi,et al.  The regulated expression of the pregnancy-associated plasma protein-A in the rodent ovary: a proposed role in the development of dominant follicles and of corpora lutea. , 2002, Endocrinology.

[38]  M. McCarthy,et al.  Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.

[39]  É. Szabó,et al.  Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  I. Jolliffe.  Principal Component Analysis , 2002 .

[41]  E. Baracat,et al.  Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.

[42]  P. Lochhead,et al.  Wnt signaling in the ovary: identification and compartmentalized expression of wnt-2, wnt-2b, and frizzled-4 mRNAs. , 2002, Endocrinology.

[43]  R. Legro,et al.  Molecular progress in infertility: polycystic ovary syndrome. , 2002, Fertility and sterility.

[44]  Regulated expression of Wnts and Frizzleds at specific stages of follicular development in the rodent ovary. , 2002, Endocrinology.

[45]  R. Anderson,et al.  Developmental changes in expression of myeloid cell leukemia-1 in human germ cells during oogenesis and early folliculogenesis. , 2002, The Journal of clinical endocrinology and metabolism.

[46]  Jorge R. Oksenberg,et al.  Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.

[47]  U. Vitt,et al.  Perspective: the ovarian kaleidoscope database-II. Functional genomic analysis of an organ-specific database. , 2002, Endocrinology.

[48]  S. Weitsman,et al.  Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters. , 2002, Fertility and sterility.

[49]  K. Nair,et al.  Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. , 2002, Diabetes.

[50]  N. Cox,et al.  Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. , 2002, The Journal of clinical endocrinology and metabolism.

[51]  J. Stark,et al.  Formation and early development of follicles in the polycystic ovary , 2003, The Lancet.

[52]  J. Richards,et al.  Expression and localization of secreted frizzled-related protein-4 in the rodent ovary: evidence for selective up-regulation in luteinized granulosa cells. , 2003, Endocrinology.

[53]  M. Urbanek,et al.  The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis* , 2003, Journal of Biological Chemistry.

[54]  Didier Dewailly,et al.  Ultrasound assessment of the polycystic ovary: international consensus definitions. , 2003, Human reproduction update.

[55]  T. Betts,et al.  A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy , 2003, Seizure.

[56]  G. Matarese,et al.  Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.

[57]  M. Laakso,et al.  Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome. , 2003, Human reproduction.

[58]  G. Eichele,et al.  Carboxypeptidase Z (CPZ) modulates Wnt signaling and regulates the development of skeletal elements in the chicken , 2003, Development.

[59]  H. Kiyokawa,et al.  The Cyclin-dependent Kinase Inhibitors p27Kip1 and p21Cip1 Cooperate to Restrict Proliferative Life Span in Differentiating Ovarian Cells* , 2003, The Journal of Biological Chemistry.

[60]  S. Chun,et al.  Regulation of NGFI-B expression during the ovulatory process , 2003, Molecular and Cellular Endocrinology.

[61]  Guoying Liu,et al.  NetAffx: Affymetrix probesets and annotations , 2003, Nucleic Acids Res..

[62]  G. Gores,et al.  AIP1: a new player in TNF signaling , 2003 .

[63]  P. Claman.  Men at risk: occupation and male infertility. , 2004, Fertility and sterility.

[64]  B. Fauser,et al.  Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. , 2004, The Journal of clinical endocrinology and metabolism.

[65]  E. Khoury,et al.  Luteinization of human granulosa cells in vivo is associated with expression of MHC Class II antigens , 1990, Cell and Tissue Research.

[66]  J. Wood,et al.  Valproate potentiates androgen biosynthesis in human ovarian theca cells. , 2004, Endocrinology.

[67]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.